- Academic Editor
-
-
-
Announcements
Open Access
Commentary
The Clinical Diagnosis and Management of Long QT Syndrome: Insights from the 2022 ESC Guidelines
Show Less
1
Department of Cardiology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, 264000 Yantai, Shandong, China
2
Department of Rheumatology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, 264000 Yantai, Shandong, China
*Correspondence: wgq198632@126.com (Guangqiang Wang)
†These authors contributed equally.
†These authors contributed equally.
Rev. Cardiovasc. Med. 2023, 24(6), 170;
https://doi.org/10.31083/j.rcm2406170
Submitted: 13 December 2022 | Revised: 12 January 2023 | Accepted: 15 January 2023 | Published: 12 June 2023
Copyright: © 2023 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract
Long QT syndrome (LQTS) is an uncommon disorder that is characterized by QT prolongation and torsade de pointes leading to sudden cardiac death. It is mainly triggered by adrenergic activation. Since LQTS is rare, it is often underdiagnosed. The updated 2022 European Society of Cardiology (ESC) guidelines aim to define the diagnosis of LQTS and spread its management. However, some unknowns and uncertainties still exist regarding the treatment of LQTS. This commentary is geared to the expansion of clinical applications of drug therapies for different subtypes of LQTS based on the 2022 ESC guidelines.
Keywords
long QT syndrome
dignosis
management
guidelines
Figures
Fig. 1.